法国新生儿李斯特菌病的长期神经与神经发育结局:前瞻性匹配观察性队列研究
本研究为法国MONALISA队列的前瞻性匹配观察性研究,评估53例经微生物学确诊的新生儿李斯特菌病患儿5岁时神经与神经发育结局,并与胎龄匹配的无感染儿童比较。结果显示66%(29/44)患儿存在至少一种发育障碍,18%(8/44)为严重障碍;
要点
- 66%(29/44)新生儿李斯特菌病存活患儿5岁时存在至少一种神经发育障碍
- 18%(8/44)患儿存在严重神经发育障碍
- 与胎龄匹配无感染儿童相比,总体障碍风险无显著差异,早产是主要贡献因素
核心结论
- 新生儿李斯特菌病存活患儿中持续残疾负担较高,但长期神经发育结局与胎龄匹配无感染儿童无显著差异。
- 早产对长期结局的贡献占主导地位。
研究设计与样本
- 法国MONALISA前瞻性匹配观察性队列研究,纳入微生物学确诊的母胎-新生儿李斯特菌病患儿。
- 结果与胎龄匹配的无感染儿童比较,对照来自EPIPAGE-2(早产儿)和ELFE(>32周胎龄的足月儿一般人群)两个国家前瞻性队列。
主要发现
- 53名儿童中31名(58%)为早产,22名(42%)为早发型全身性感染,18名(34%)为早发型非全身性感染,6名(11%)为晚发型全身性感染且均伴脑膜炎。
- 44名可获取神经发育障碍评分的儿童中,29名(66%)发生至少一种障碍,8名(18%)为严重神经发育障碍。
- 4名可获取评分的晚发型感染患儿中,3名发生至少一种神经发育障碍。
临床怎么用
- 对新生儿李斯特菌病存活患儿应实施系统性长期筛查,关注神经发育障碍。
- 根据评估结果提供针对性教育和特殊需求支持。
- 临床随访中需特别关注早产这一主要风险因素对长期结局的影响。
局限性
- 研究为观察性队列,样本量有限(53名儿童纳入神经发育评估,44名可获取障碍评分)。
- 晚发型感染伴脑膜炎患儿仅6名,其中可获取评分者仅4名,相关结论证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maternal-neonatal listeriosis is a rare and serious infection. The long-term outcome of surviving infants with early-onset or late-onset listeriosis remains unknown. We aimed to determine the long-term neurological and neurodevelopmental outcome of neonatal listeriosis. METHODS: In this prospective, matched, observational cohort study, we evaluated children born with microbiologically confirmed maternal-neonatal listeriosis in the French MONALISA cohort. At age 5 years, children underwent neurological and neurodevelopmental assessments of sensory deficits, executive function, adaptive behaviour, and cognitive and motor coordination function. The cognitive domain was assessed using the French version of the Wechsler Preschool and Primary Scale of Intelligence, fourth edition, and scored by Full Scale Intelligence Quotient (FSIQ). The motor domain was assessed by physical examination designed to screen for cerebral palsy and developmental coordination disorder. Executive functioning was assessed using the statue and inhibition subtests of Neuropsychological Assessment, second version. The sensory domain was assessed by parental interview, medical report, and clinical assessment. Adaptive behaviour was measured using the Vineland-II behaviour scale from parent-reported assessments of functional communication, socialisation, daily living, and motor skills. Results were compared with gestational age-matched children from two national prospective cohorts: EPIPAGE-2 (preterm infants) and ELFE (term infants from a general population of infants >32 weeks gestation). This study is registered with ClinicalTrials.gov (NCT02580812). FINDINGS: Of 59 children who were alive and eligible to participate in the study, 53 (median age 5 years, IQR 5-6) were enrolled for neurodevelopmental assessments between Oct 26, 2016, and Oct 29, 2019. Of 53 children, 31 (58%) had been born preterm, 22 (42%) had early-onset systemic infection, 18 (34%) had early-onset non-systemic infection, and six (11%) had late-onset systemic infection, all with meningitis. 29 (66%) of 44 children, in whom neurodevelopmental disabilities scores were available, developed at least one disability; eight (18%) children had severe neurodevelopmental disabilities. Of four children with late-onset infection and in whom neurodevelopmental disabilities scores were available, three developed at least one neurodevelopmental disability. Neurological and neurodevelopmental outcomes of children with neonatal listeriosis did not differ from those of gestational age-matched control children without infection (relative risk [RR] of at least one disability 0·99 [95% CI 0·65-1·51; p=0·97]; RR of FSIQ less than -1 SD 0·92 [0·54-1·54; p=0·74]). INTERPRETATION: These results highlight the burden of persistent disability and dominant contribution of prematurity to long-term outcomes in children born with neonatal listeriosis. The findings support the implementation of systematic long-term screening and provision of tailored education and special needs support. FUNDING: Institut Pasteur, Inserm, French Public Health Agency, Contrat de Recherche Clinique, and Assistance Publique-Hôpitaux de Paris.
引用
- Charlier C, Barrault Z, Rousseau J, et al. Long-term neurological and neurodevelopmental outcome of neonatal listeriosis in France: a prospective, matched, observational cohort study. Lancet Child Adolesc Health. 2023. PMID: 37871603. doi:10.1016/S2352-4642(23)00195-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。